Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.20 -1.37 (-4.80%)
At close: Oct 23, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Cash & Current Investments (2021 - 2026)

Updated

Amylyx Pharmaceuticals (AMLX) recorded Cash & Current Investments of $250.76 million in Q2 2026, up 38.7% from $180.83 million a year earlier but down 10.4% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Cash & Current Investments (2021 - 2026) Analysis & Trends

At the end of FY2025, Amylyx Pharmaceuticals reported Cash & Current Investments of $316.98 million, up 79.6% from FY2024.

  • Annual Cash & Current Investments has a four-year compound annual growth rate of 34.8% (FY2021 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $176.5 million in FY2024 (-52.5%), $371.36 million in FY2023 (+7.0%), $346.95 million in FY2022 (+261.0%) and $96.12 million in FY2021.
  • Quarterly Cash & Current Investments has ranged from $96.12 million in Q4 2021 to $373.29 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 3.6% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 261.0% in Q4 2022, against a decline of 52.5% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $279.77 million (Q1 2026), $316.98 million (Q4 2025) and $343.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Amylyx Pharmaceuticals 3.03 Bn 1.83 Bn - 250.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250.76 Mn
Mar 31, 2026 279.77 Mn
Dec 31, 2025 316.98 Mn
Sep 30, 2025 343.99 Mn
Jun 30, 2025 180.83 Mn
Mar 31, 2025 204.07 Mn
Dec 31, 2024 176.50 Mn
Sep 30, 2024 234.40 Mn
Jun 30, 2024 309.81 Mn
Mar 31, 2024 373.29 Mn
Dec 31, 2023 371.36 Mn
Sep 30, 2023 355.05 Mn
Jun 30, 2023 357.28 Mn
Mar 31, 2023 345.67 Mn
Dec 31, 2022 346.95 Mn
Sep 30, 2022 162.59 Mn
Jun 30, 2022 206.68 Mn
Mar 31, 2022 255.21 Mn
Dec 31, 2021 96.12 Mn
API Access

Amylyx Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMLX&period=max&api_key=YOUR_API_KEY